One study showed that, compared with the control group, 43% of patients with NASH showed clinical improvement with significant reductions in their ALT and AST levels and lobular inflammation after treatment with vitamin E [105]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.